Olema Pharmaceuticals Inc (OLMA) — Defensive Interval Ratio
Olema Pharmaceuticals Inc (OLMA) has a Defensive Interval Ratio of 3504 days as of March 2026. Defensive assets of $452.80 Million (cash $-, short-term investments $452.80 Million, receivables $-) cover 3504 days of daily cash needs of $129.22K/day. See working capital to net assets of Olema Pharmaceuticals Inc to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Olema Pharmaceuticals Inc Defensive Interval Ratio (2020–2025)
This chart shows how Olema Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the ratio stands at 3504 days, meaning defensive assets of $452.80 Million can fund 3504 days of operations without new revenue. See OLMA net asset quality score to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Olema Pharmaceuticals Inc (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for Olema Pharmaceuticals Inc from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Olema Pharmaceuticals Inc stock valuation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 3250 days | $461.19 Million | $141.92K/day | $- | $457.14 Million | ▲ +656 days |
| 2024 | 2594 days | $296.73 Million | $114.41K/day | $- | $294.61 Million | ▼ -680 days |
| 2023 | 3274 days | $193.94 Million | $59.24K/day | $- | $193.27 Million | ▼ -719 days |
| 2022 | 3993 days | $181.04 Million | $45.34K/day | $- | $180.72 Million | ▼ -7078 days |
| 2021 | 11071 days | $273.57 Million | $24.71K/day | $- | $273.44 Million | ▲ +11071 days |
| 2020 | 0 days | $0.00 | $12.56K/day | $- | $0.00 | — |